Lysozyme-containing chitosan-coated alginate microspheres for oral immunisation

Journal of Drug Delivery Science and Technology

Volumn 16, Issue 6, 2006, Pages 413-420

  Zorzin, L ^a   Cocchietto, M ^a   Voinovich, D ^b   Marcuzzi, A ^a   Filipovic Grcic J ^c   Mulloni, C ^a   Crembiale, G ^a   Casarsa, C ^a   Bulla, R ^b   Sava, G ^a,b  

^a Callerio Foundation   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Biopolymers; Lysozyme; Mouse; Oral; Vaccine

Indexed keywords

ALGINIC ACID; BACTERIAL ANTIGEN; CHITOSAN; IMMUNOGLOBULIN A; LYSOZYME; MICROSPHERE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG SCREENING; ENCAPSULATION; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOMODULATION; LISTONELLA ANGUILLARUM; MICROENCAPSULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ZETA POTENTIAL;

EID: 33846314387     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(06)50081-4     Document Type: Article

References (36)

1. Joosten P.H.M., Tiemersma E., Threels A., Caumartin-Dhieux C., Rombout J.H.W. - Oral vaccination of fish against Vibrio anguillarum using alginate microparticles. - Fish Shellfish Immunol., 7, 471-485, 1997.
2. Dunn E.J., Polk A., Scarrett D.J., Olivier G., Lall S., Goosen M.F.A. - Vaccines in aquaculture: The search for an efficient delivery system. - Aquacult. Eng., 9, 23-32, 1990.
3. Bowersock T.L., Hogenesch H., Suckow M., Guimon P., Martin S., Borie D., Torregrosa S., Park H., Park K. - Oral vaccination of animals with antigens encapsulated in alginate microspheres. - Vaccine, 17, 1804-1811, 1999.
4. Sihna V.R., Trehan A. - Biodegradable micro-spheres for protein delivery. - J. Control. Release, 90, 261-280, 2003.
5. Vasir J.K., Tambwekar K., Garg S. - Bioadhesive microspheres as a controlled drug delivery system. - Int.J.Pharm., 255, 13-32, 2003.
6. De S., Robinson D. - Polymer relationships during preparation of chitosan-alginate and poly-l-lysine-alginate nanospheres. - J. Control. Release, 89, 101-112, 2003.
7. Shu X.Z., Zhu K.J. - The release behaviour of brilliant blue from calcium alginate beads coated by chitosan: the preparation method effect. - Eur. J. Pharm. Biopharm., 53, 193-201, 2002.
8. Martinsen A., Skjåk-Bræk G., Smidsrød O. - Alginate as immobilization material: I Correlation between chemical and physical properties of alginate gel beads. - Biotech. Bioeng., 33, 79-89, 1989.
9. Polk A., Amsden B., De Yao K., Peng T., Goosen F.A. - Control-led release of albumin from chitosan-alginate microcapsules. - J. Pharm. Sci., 83 (2), 178-185, 1994.
10. 2 system for membrane coat application - J. Pharm. Sci., 90 (8), 1134-1142, 2001.
11. Vandenberg G. W., Drolet C., Scott S.L., de la Noue J. - Factors affecting protein release from alginate-chitosan coacervate microcapsules during production and gastric/intestinal simulation - J. Contr. Release, 77: 297-301, 2001.
12. Süheyla Kas H. - Chitosan: properties, preparation and application to microparticulate systems. - J. Microencaps., 14 (6), 689-711, 1997.
13. Takka S., Ocak O.H., Acartürk F. - Formulation and investigation of nicardipine HCI-alginate gel beads with factorial design-based studies. - Eur. J. Pharm. Sci., 6, 241-246, 1998.
14. Shao M., Ma Y., Liu Q., Zhang Y. - Secretory expression of recombinant proteins in an attenuated Vibrio anguillarum strain for potential use in vaccines. - J. Fish Dis., 28 (12), 723-728, 2005.
15. Bowden T.J., Menoyo-Luque D., Bricknell I.R., Wergeland H. - Efficacy of different administration routes for vaccination against V. anguillarum in Atlantic halibut (Hippoglossus hippoglossus). - Fish Shellfish Immunol., 12, 283-285, 2002.
16. Reitano S., Kayhko K., Osserman E.F. - Human lysozyme induces proliferation of human peripheral blood lymphocytes. - Fed. Proceedings, 41, 608, 1982.
17. Cartei F., Cartei G., Ceschia V., Pacor S., Sava G. - Recovery of lymphocyte CD4+/CD8+ ratio by lysozyme treatment. - Drug Invest., 4, 51, 1991.
18. Sava G. - Pharmacological aspects and therapeutic applications of lysozymes. - In: Jollès P. (Ed.), Lysozyme: Model Enzymes in Biochemistry and Biology, Basel, Birkhäuser Verlag, 1996, pp. 433-449.
19. Dubey R.R., Parikh R.H. - Two-stage optimization process for formulation of chitosan microspheres. - AAPS PharmSciTech., 5 (1), 1-9, 2004.
20. Biomedical Engineering 3101, Protein Ort, Section III, Week 11, Fall 2001.
21. Pacor S., Giacomello E., Bergamo A., Gagliardi R., Cocchietto M., Sava G. - Cytofluorimetric analysis of gut-intraepithelial and mesenteric lymph node lymphocytes of tumour bearing mice fed with egg-white lysozyme. - Anticancer Res., 16, 145-150, 1996.
22. Palm Jr. R.C., Landolt M.L., Busch R.A. - Route of vaccine administration: effects on the specific humoral response in rainbow trout Oncorhynchus mykiss. - Dis. Aquat. Organ., 33, 157-166, 1998.
23. O'Hagan DT. - The intestinal uptake of particles and the implications for drug and antigen delivery. - J Anat., 189, 477-82, 1996.
24. Florence A.T. - The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. - Pharm. Res., 14 (3), 259-66, 1997.
25. Wan L.S., Heng P.W., Chan L.W. - Drug encapsulation in alginate microspheres by emulsification. - J Microencapsul., 9 (3), 309-16, 1992.
26. Hashida S., Ishikawa E., Nakamichi N., Sekino H. - Concentration of egg white lysozyme in the serum of healthy subjects after oral administration. - Clin. Exp. Pharmacol. Physiol., 29, 79-83, 2002.
27. Oki A., Serarz E. - T cell tolerance studied at the level of antigenic determinants. Latent reactivity to lysozyme peptides that lack suppressogenic epitopes can be revealed in lysozyme-tolerant mice. - J. Exp. Med., 161, 897, 1985.
28. Allen P.M., Strydom D.J., Unanue E.R.- Processing of lysozyme by macrophages: identification of the determinant recognized by two T-cell hybridomas. - Proceedings Nat. Acad. Sci. USA, 81, 2489, 1984.
29. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley P.M., Tice T.R. - Controlled vaccine release in the gut-associated lymphoid tissue. I. Orally administered biodegradable microspheres target the Peyer's patches. - J. Control. Release, 11, 205-214, 1990.
30. Bayens V., Gurny R. - Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations - Pharm. Acta Helv., 72, 191-202, 1997.
31. Fewng S., Huang G. - Effects of emulsifier on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers - J. Contr. Release, 71, 53-69, 2001.
32. Paniagua E., Paramá A., Iglesias R., Sanmartín M.L., Leiro J. - Effects of bacteria on the growth of an amoeba infecting the gills of turbot. - Dis. Aquat. Org., 45, 73-76, 2001.
33. Eguchi M., Fujiwara E., Mijamoto N. - Survival of V. anguillarum in freshwater environments: adaptation or debilitation?-J. Infec. Chemother., 6, 126-129, 2000.
34. Watts M., Munday B.L., Burke C.M. - Immune responses of teleost fish. - Aust. Vet. J., 79, 570-574, 2001.
35. Verschuere L., Rombaut G., Sorgeloos P., Verstraete W. - Probiotic bacteria as biological control agents in aquaculture. - Microbiol. Mol. Biol. Rev., 64, 655-671, 2000.
36. Paolini A., Ridolfi V., Zezza D., Gusmani L., Cocchietto M., Musa M., Pavone A., Conte A.E., Giorgetti G. - Prove di vaccinazione della spigola (Dicentrarchus labrax) contro la Pasteurellosi mediante somministrazione orale, intraperitoneale e per immersione. - Veterinaria Italiana, 41 (2), 7-14, 2005.